Search results
Showing 1186 to 1200 of 1373 results for social care
Find out more about the NICE technology appraisal advisory committee B members and their registered interests
Our associates help us to support high quality, safe, cost-effective prescribing and medicines optimisation.
Panobinostat for treating multiple myeloma after at least 2 previous treatments (TA380)
Evidence-based recommendations on panobinostat (Farydak) for treating multiple myeloma after at least 2 previous treatments.
View recommendations for TA380Show all sections
depression and their families or carers (as appropriate) receive the best possible care and can take part in shared decision making, the...
depression and their families or carers (as appropriate) receive the best possible care and can take part in shared decision making, the...
share the same mission: helping practitioners and commissioners get the best care to patients fast, while ensuring value for the...
Access to a range of journals, databases and other evidence-based resources for health and social care staff in England.
Learn from NICE International, part of the UK's National Institute for Health and Care Excellence, about how to improve your nation's health and wellbeing
Agenda and papers of the NICE public board meeting on 18 September 2025
used to give us an understanding of public opinion on moral, ethical and social value issues. It helps us make sure that our policies on...
NICE work with the NHS, patients and carers, healthcare professionals and organisations to help put our guidance into practice.
International collaboration with NICE
Our projects and partnerships help us anticipate and adapt to policy developments, including changes in health and social care delivery.
Highly specialised technology (HST) evaluations are recommendations on the use of new and existing highly specialised medicines and treatments within the NHS in England.
Details about the chair and core members of NICE public health advisory committee F.